Lowest recommended Gd dose 
among general-use GBCAs

 

VUEWAY® provides effective contrast enhancement at half the gadolinium dose

(0.05 mmol/kg) vs. a macrocyclic GBCA at a dose of 0.1 mmol/kg in approved indications.1

table dosing corrected
Charts adapted from Robic C et al. Invest Radiol 2019

References

 

1 VUEWAY® (gadopiclenol) SmPC, EMA, 10/2022.

2 Robic C, Port M, Rousseaux O, et al. Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate with High T1 Relaxivity. Invest Radiol. 2019; 54: 475-484.

3 GADOVIST® (gadobutrol) SmPC, 07/2022.

4 ProHance® (gadoteridol) SmPC UK, 11/2022.

5  DOTAREM® (gadoterate meglumine) SmPC 07/2022.

6 CLARISCAN™ (gadoterate meglumine) SmPC UK, 05/2023.